A new era in migraine therapy

Theranica is a medical technology company that has developed and received FDA clearance/EU approval for a neurostimulation patch that treats migraine. The wearable, Nerivio™, is applied to the upper arm and activated by a smartphone app which begins a 30-40 minute session that stimulates endogenous pain inhibitory mechanisms in the brain through electrical neuromodulation. Results from numerous large-scale clinical studies show efficacy results as good as the gold standard pharmacological treatments without any of the side effects associated with these drugs. Data is central to the platform as it helps patients diarize their migraines, share information with MDs and personalize their settings. Future developments will revolve around using data to help predict and intervene earlier in the hopes of preventing migraine attacks.

Investing partner / fund: